Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.

20:49 12/12/2025

Meipu Medical (301033.SZ) announced that the company has received notification letters from its shareholders Shenzhen Kaiying and Fengyan Fund regarding their plans to reduce their shareholdings. Shenzhen Kaiying plans to reduce no more than 150,000 shares, which is equivalent to 0.2237% of the total share capital of the company; Fengyan Fund plans to reduce no more than 668,100 shares, accounting for 0.9964% of the current share capital of the company (1.0000% excluding the shares held in the company's repurchase special account).

Medprin Regenerative Medical Technologies (301033.SZ) announcement, the company has received notification letters from shareholders Shenzhen Kaiying and Fengyan Fund regarding their plans to reduce their shareholding. Shenzhen Kaiying plans to reduce no more than 150,000 shares, or 0.2237% of the total share capital of the company; Fengyan Fund plans to reduce no more than 668,100 shares, accounting for 0.9964% of the current share capital of the company (excluding the shares held in the company's repurchase account, the percentage is 1.0000%).

LUYE PHARMA (02186) subsidiary completed the issuance of 1.5 million shares of convertible preferred stock.

ASIA TELE-NET (00679) announced on December 12 that it will spend 182,000 Hong Kong dollars to repurchase 200,000 shares.

The controlling shareholder of ES Services (01995) intends to sell approximately 23.54% of the company's shares.

LUYE PHARMA (02186) subsidiary completed the issuance of 1.5 million shares of convertible preferred stock.

ASIA TELE-NET (00679) announced on December 12 that it will spend 182,000 Hong Kong dollars to repurchase 200,000 shares.

The controlling shareholder of ES Services (01995) intends to sell approximately 23.54% of the company's shares.